Perez, Elviliza T.
HRN: 06-68-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/02/2024
03/08/2024
IV
600
Every 8 Hours
Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes